The Alcohol Withdrawal Syndrome
Lancet 349:1897-1900, Hall,W.&Zador,D., 1997

Resolution of a Brainstem Abscess Through Antituberculous Therapy
Neurol 49:265-267, Garcia-Monco,J.C.,et al, 1997

The Diagnostic Evaluation & Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA 278:51-57, Gutmann,D.H.,et al, 1997

Albendazole Therapy for Neurocysticercosis:A Prospective Double-Blind Trial Comparing 7 vs 14 Days of Treatment
Neurol 48:1421-1427, Garcia,H.H.,et al, 1997

Clinical Trial of Plasma Exchange and High-dose Intravenous Immunoglobulin in Myasthenia Gravis
Ann Neurol 41:789-796, Gajdos,P.,et al, 1997

Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997

Myasthenic Crisis:Clinical Features, Mortality, Comp, & Risk Factors for Prolonged Intubation
Neurol 48:1253-1254, Thomas,C.E.,et al, 1997

Lumboperitoneal Shunting for Pseudotumor Cerebri
Neurol 49:734-739, Burgett,R.A.,et al, 1997

Treatment of Hepatic Encephalopathy
NEJM 337:473-479, Riordan,S.M.,et al, 1997

Optic Atrophy and Cerebral Infarcts Caused by Methanol Intoxication:MRI
Neuroradiology 39:192-194, Hsu,H.H.,et al, 1997

Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997

Frequent & Frequently Overlooked:Trtm-Induced Endocrine Dysf in Adult Long-Term Survivors of Primary Brain Tumors
Neurol 49:498-506, Arlt,W.,et al, 1997

Spinal Epidural Metastasis as the Initial Manifestation of Malignancy:Clinical Features and Diagnostic Approach
Neurol 49:452-456, Schiff,D.,et al, 1997

Paraneoplastic Cerebellar Degeneration
Arch Int Med 157:1258-1262, Bolla,L.&Palmer,R.M., 1997

Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997

Meningiomas:The Decision Not to Operate
Neurol 48:1459-1462, Braunstein,J.B.&Vick,N.A., 1997

Apraxia of Lid Opening
Neurol 48:1491-1503, Boghen,D., 1997

A Double-Blind Controlled Study of Gabapentin and Baclofen as Treatment for Acquired Nystagmus
Ann Neurol 41:818-825, Averbuch-Heller,L.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Benztropine vs Clozapine for the Treatment of Tremor in Parkinson's Disease
Neurol 48:1077-1081, Friedman,J.H.,et al, 1997

Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997

Posteroventral Medial Pallidotomy in Levodopa-Unresponsive Parkinsonism
Arch Neurol 54:1026-1029, Krauss,J.K.,et al, 1997

Stereotactic Pallidotomy for Parkinson's Disease:A Long-Term Follow-up of Unilateral Pallidotomy
Neurol 48:1273-1277, Fazzini,E.,et al, 1997

Posteroventral Pallidotomy in a Patient with Parkinsonism Caused by Hypoxic Encephalopathy
Neurol 49:707-710, Goto,S.,et al, 1997

Olanzapine:A Novel Atypical Neuroleptic Agent
Lancet 349:1264-1265, Reus,V.I., 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997

Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997

Gabapentin for Idiopathic Trigeminal Neuralgia:Report of Two Cases
Neurol 48:1467, Sist,T.,et al, 1997

Clinical Effectiveness of Lamotrigine and Plasma Levels in Essential and Symptomatic Trigeminal Neuralgia
Neurol 48:1714-1717, Lunardi,G.,et al, 1997

Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997

The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997

Cryptic Vascular Malformations:Controversies in Terminology, Diagnosis, Pathophysiology, and Treatment
AJNR 18:1839-1846, Dillon,W.P., 1997

Thrombotic Thrombocytopenic Purpura:A Treatable Cause of Childhood Encephalopathy
J Pediatr 130:313-316, Lawlor,E.R.,et al, 1997

Large Cerebral Infarction During Praziquantel Therapy in Neurocysticercosis
Stroke 28:211-213, Bang,O.Y.,et al, 1997

Is the Course of Neurocysticercosis Modified by Treatment with Anthelmintic Agents
Arch Int Med 157:128-129, DelBrutto,O.H., 1997

Outcomes and Costs After Hip Fracture and Stroke, A Comparison of Rehab Settings
JAMA 277:396-404, Kramer,A.M.,et al, 1997

Consensus Against Both Endarterectomy and Routine Screening for Asymptomatic Carotid Artery Stenosis
Arch Neurol 54:25-28, 231997., Perry,J.R.,et al, 1997

Intracranial Aneurysms
NEJM 336:28-40, Schievink,W.I., 1997

Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997

When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997

Pupil-Involving Third-Nerve Palsy and Carotid Stenosis:Rapid Recovery Following Endarterectomy
Ann Neurol 41:273-276, Balcer,L.J.,et al, 1997

Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997

Giant Lambl Excrescences:An Unusual Source of Cerebral Embolism
Arch Neurol 54:41-44, Nighoghossian,N.,et al, 1997

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

Myelinolysis After Correction of Hyponatremia
Ann Int Med 126:57-62, Laureno,R.&Karp,B., 1997